Earnings FeedTerminal

⌘K

Home/Filings/6-K/0001213900-25-118747

6-K//Foreign company update

XTL BIOPHARMACEUTICALS LTD 6-K

Accession 0001213900-25-118747

$XTLBCIK 0001023549other

View on SEC.gov Company Profile

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 4:30 PM ET

Size

13.2 KB

Accession

0001213900-25-118747

Documents

1 file

6-K
ea0268692-6k_xtlbio.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER

Issuer

XTL BIOPHARMACEUTICALS LTD

CIK 0001023549

Entity typeother

IncorporatedIsrael

Related Parties

1

filerCIK 0001023549

Filing Metadata

Form type: 6-K
Filed: Dec 4, 7:00 PM ET
Accepted: Dec 5, 4:30 PM ET
Size: 13.2 KB

View on SEC.gov